AAV |
Adeno-associated virus |
AIT |
Allergen-specific immunotherapy |
Alum |
Aluminum hydroxide |
APC |
Antigen presenting cell |
cAMP |
Cyclic adenosine monophosphate |
CT |
Cholera toxin |
CNS1 |
Non-coding DNA sequence 1 |
DC |
Dendritic cell |
DAMP |
Damage associated molecular pattern |
GATA3 |
GATA binding protein 3 |
GM-CSF |
Granulocyte-macrophage colony-stimulating factor |
HSC |
Hematopoietic stem cells |
IL(-25) |
Interleukin (25) |
ILC2s |
Innate like lymphocytes type II cells |
iTregs |
Induced Tregs |
LPS |
Lipopolysaccharide |
MAPK |
Mitogen-activated protein kinase |
mMCP1 |
Mouse mast cell protease 1 |
NFκB |
Nuclear factor “kapa-light-enhancer“ of activated B cells |
NOD |
Non-obese diabetic |
Ova |
Ovalbumin |
PBMC |
Peripheral blood mononuclear cells |
SCID |
Severe combined immunodeficiency |
SCF |
Stem cell factor |
SEB |
Staphylococcus enterotoxin B |
TCR |
T cell receptor |
Th1/2/17 |
T helper 1/2/17 cell |
TLR(4) |
“Toll“-like receptor (4) |
(i)Treg |
(Peripherally induced) regulatory T cell |
TSLP |
Thymic stromal lymphopoietin |
WAS(P) |
Wiskott-Aldrich syndrome (protein) |